Press Releases

RSS
  • Dec 18, 2017
    ENGLEWOOD, Colo., Dec. 18, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced the appointment of David A. Green as Chief Financial Officer.  Mr. Green is a highly accomplished CFO, who brings an extensive array of financial, accounting, and operational experien...
    Nov 28, 2017
    ENGLEWOOD, Colo., Nov. 28, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an update on the launch of Natesto in the U.S.  Significant Natesto prescription growth continued through October 2017, with prescriptions increasing 17% from the previous month, reachi...
    Nov 9, 2017
    ENGLEWOOD, Colo., Nov. 9, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an overview of its business, including the Company's operational and financial results for its fiscal first quarter of 2018.  The Company will host a live conference call and webcast to...
    Nov 7, 2017
    ENGLEWOOD, Colo., Nov. 7, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the Australian Government Department of Health and Therapeutic Goods Administration (TGA) has approved the MiOXSYS® System for inclusion on the Australian Register of Therapeutic G...
    Nov 2, 2017
    ENGLEWOOD, Colo., Nov. 2, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the Company will present its operational results for the fiscal first quarter 2018 on Thursday, November 9, 2017, at 4:30 p.m. ET.  The Company will review recent accomplishments a...
    Nov 1, 2017
    ENGLEWOOD, Colo., Nov. 1, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that it presented six posters demonstrating the clinical potential of MiOXSYS®, the company's rapid in vitro diagnostic system for the qualitative measurement of static oxidation-reduc...
    Oct 26, 2017
    ENGLEWOOD, Colo., Oct. 26, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an update on the ongoing launch of Natesto in the U.S.  Through September 30 -- the end of the Company's fiscal first quarter 2018 -- Natesto prescriptions and factory sales significan...
    Oct 19, 2017
    ENGLEWOOD, Colo., Oct. 19, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the Company will ring the NASDAQ closing bell on Friday, October 20, 2017 at 4:00 p.m. EDT....
    Oct 18, 2017
    ENGLEWOOD, Colo., Oct. 18, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that its shares of common stock were approved for listing on The NASDAQ Capital Market. Trading on The NASDAQ Capital Market will commence on Friday October 20th, 2017.  The Company's ...
    Oct 9, 2017
    Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation...